# Study of Standardized Withaferin-A for the Treatment of Steroid Refractory Acute Graft Versus Host Disease.

> **NCT07708987** · PHASE2 · RECRUITING · sponsor: **Tata Memorial Centre** · enrollment: 34 (estimated)

## Conditions studied

- Hematological Malignancy
- GVHD - Graft-Versus-Host Disease
- Steriod Refractory

## Interventions

- **DRUG:** Standardized Withaferin A (SWA)

## Key facts

- **NCT ID:** NCT07708987
- **Lead sponsor:** Tata Memorial Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-23
- **Primary completion:** 2028-01-09
- **Final completion:** 2028-09-25
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2026-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07708987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07708987, "Study of Standardized Withaferin-A for the Treatment of Steroid Refractory Acute Graft Versus Host Disease.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07708987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*